Growth Metrics

Rigel Pharmaceuticals (RIGL) Return on Capital Employed Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,255.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 31,429.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2,503.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,400.00
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -1,282.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,282.00
Dec 31, 2025 1,763.00
Sep 30, 2025 7,940.00
Jun 30, 2025 11,298.00
Mar 31, 2025 7,278.00
Dec 31, 2024 5,989.00
Sep 30, 2024 4,193.00
Jun 30, 2024 3,185.00
Mar 31, 2024 2,009.00
Dec 31, 2023 6,048.00
Sep 30, 2023 7,605.00
Jun 30, 2023 5,127.00
Mar 31, 2023 3,099.00
Dec 31, 2022 -8,197.00
Sep 30, 2022 -9,870.00
Jun 30, 2022 -9,361.00
Mar 31, 2022 -7,393.00
Dec 31, 2021 2,716.00
Sep 30, 2021 2,117.00
Jun 30, 2021 2,168.00
Mar 31, 2021 1,856.00
Dec 31, 2020 3,563.00
Sep 30, 2020 1,082.00
Jun 30, 2020 2,093.00
Mar 31, 2020 2,512.00
Dec 31, 2019 -352.00
Sep 30, 2019 5,082.00
Jun 30, 2019 4,723.00
Mar 31, 2019 4,666.00
Dec 31, 2018 3,332.00
Sep 30, 2018 1,904.00
Jun 30, 2018 308.00
Mar 31, 2018 -342.00
Dec 31, 2017 1,110.00
Sep 30, 2017 -1,826.00
Jun 30, 2017 -3,351.00
Mar 31, 2017 -3,900.00
Dec 31, 2016 -6,381.00
Sep 30, 2016 -3,460.00
Jun 30, 2016 -48.00
Mar 31, 2016 1,404.00
Dec 31, 2015 1,218.00
Sep 30, 2015 -356.00
Jun 30, 2015 -1,303.00
Mar 31, 2015 -2,772.00
Dec 31, 2014 -2,287.00
Sep 30, 2014 -1,227.00
Jun 30, 2014 -1,071.00
Mar 31, 2014 -623.00
Dec 31, 2013 120.00
Sep 30, 2013 1,094.00
Jun 30, 2013 511.00
Mar 31, 2013 198.00
Dec 31, 2012 -754.00
Sep 30, 2012 -2,225.00